Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis

Peer Review reports

Original Submission
21 Aug 2020	Submitted	Original manuscript
4 Dec 2020	Reviewed	Reviewer Report - Vincenzo L'imperio
26 Dec 2020	Reviewed	Reviewer Report - Yonggang Zhang
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
11 Jan 2021	Editorially accepted
21 Jan 2021	Article published	10.1186/s13643-021-01588-7

Back to article page